Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antagonism of Neostigmine in Continuous Infusion of Mivacurium: a Randomised Controlled Trial

NCT07524959 is registered in ClinicalTrials.gov with Beijing Tongren Hospital as lead sponsor.

NCT NCT07524959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07524959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antagonism of Neostigmine in Continuous Infusion of Mivacurium: a Randomised Controlled Trial
Lead sponsor
Beijing Tongren Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
July 29, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular blocking agents